NF-E2 overexpression delays erythroid maturation and increases erythrocyte production

British Journal of Haematology

Volumn 146, Issue 2, 2009, Pages 203-217

  Mutschler, Manuel ^a   Magin, Angela S ^a   Buerge, Martina ^a   Roelz, Roland ^a   Schanne, Daniel H ^a   Will, Britta ^a   Pilz, Ingo H ^a   Migliaccio, Anna Rita ^b   Pahl, Heike L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CD34+ cells; Myeloproliferative disorders; Transcription factors

Indexed keywords

ERYTHROPOIETIN; TRANSCRIPTION FACTOR NRF2;

ARTICLE; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; COLONY FORMATION; ERYTHROCYTOSIS; ERYTHROID CELL; ERYTHROPOIESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL;

ANTIGENS, CD34; ERYTHROCYTES; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; HUMANS; NF-E2 TRANSCRIPTION FACTOR; POLYCYTHEMIA; POLYCYTHEMIA VERA;

EID: 67649939209     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07742.x     Document Type: Article

References (41)

1. Andrews, N., Erdjument-Bromage, H., Davidson, M.B., Tempst, P. Orkin, S.H. (1993) Erythroid transcription factor NF-E2 is a hematopoietic-specific basic-leucine zipper protein. Nature, 362, 722 728.
2. Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. Green, A.R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054 1061. (Pubitemid 40386783)
3. Bellanné-Chantelot, C., Chaumarel, I., Labopin, M., Bellanger, F., Barbu, V., De Toma, C., Delhommeau, F., Casadevall, N., Vainchenker, W., Thomas, G. Najman, A. (2006) Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood, 108, 346 352. (Pubitemid 43990648)
4. Campbell, P., Baxter, E., Beer, P., Scott, L., Bench, A., Huntly, B., Erber, W., Kusec, R., Larsen, T., Giraudier, S., Le Bousse-Kerdilès, M., Griesshammer, M., Reilly, J., Cheung, B., Harrison, C. Green, A. (2006) Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations and role in leukemic transformation. Blood, 108, 3548 3555. (Pubitemid 44776897)
5. Cario, H., Goerttler, P.S., Steimle, C., Levine, R.L. Pahl, H.L. (2005) The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera. British Journal of Haematology, 130, 800 801. (Pubitemid 43906658)
6. Dupont, S., Masse, A., James, C., Teyssandier, I., Lecluse, Y., Larbret, F., Ugo, V., Saulnier, P., Koscielny, S., Le Couedic, J.P., Casadevall, N., Vainchenker, W. Delhommeau, F. (2007) The JAK2 V617F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood, 110, 1013 1021. (Pubitemid 47267441)
7. Eaves, A.C. Eaves, C.J. (1984) Erythropoiesis in culture. Clinical Haematology, 13, 371 391. (Pubitemid 15192407)
8. Garcon, L., Lacout, C., Svinartchouk, F., Le Couedic, J.P., Villeval, J.L., Vainchenker, W. Dumenil, D. (2005) Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood, 105, 1448 1455. (Pubitemid 40223660)
9. Geron, I., Abrahamsson, A.E., Barroga, C.F., Kavalerchik, E., Gotlib, J., Hood, J.D., Durocher, J., Mak, C.C., Noronha, G., Soll, R.M., Tefferi, A., Kaushansky, K. Jamieson, C.H. (2008) Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors. Cancer Cell, 13, 321 330.
10. Goerttler, P.S., Kreutz, C., Donauer, J., Faller, D., Maiwald, T., Marz, E., Rumberger, B., Sparna, T., Schmitt-Graff, A., Wilpert, J., Timmer, J., Walz, G. Pahl, H.L. (2005) Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2. British Journal of Haematology, 129, 138 150. (Pubitemid 40524062)
11. Guglielmelli, P., Zini, R., Bogani, C., Salati, S., Pancrazzi, A., Bianchi, E., Mannelli, F., Ferrari, S., Le Bousse-Kerdiles, M.C., Bosi, A., Barosi, G., Migliaccio, A.R., Manfredini, R. Vannucchi, A.M. (2007) Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells, 25, 165 173. (Pubitemid 46052987)
12. James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144 1148. (Pubitemid 40663494)
13. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T. Kumagai, H. (2003) Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Experimental Hematology, 31, 1007 1014. (Pubitemid 37329742)
14. Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. Skoda, R.C. (2005a) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 1779 1790. (Pubitemid 40570926)
15. Kralovics, R., Teo, S.S., Buser, A.S., Brutsche, M., Tiedt, R., Tichelli, A., Passamonti, F., Pietra, D., Cazzola, M. Skoda, R.C. (2005b) Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood, 106, 3374 3376. (Pubitemid 41609168)
16. Kralovics, R., Teo, S.S., Li, S., Theocharides, A., Buser, A.S., Tichelli, A. Skoda, R.C. (2006) Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood, 108, 1377 1380. (Pubitemid 44232040)
17. Kruisbeck, A.M., Margulies, D.H., Shevach, E.M. Strober, W. (1991) Current Protocols in Immunology. John Wiley & Sons, New York.
18. Labbaye, C., Valtieri, M., Barberi, T., Meccia, E., Masella, B., Pelosi, E., Condorelli, G.L., Testa, U. Peschle, C. (1995) Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. Journal of Clinical Investigation, 95, 2346 2358.
19. Lacout, C., Pisani, D.F., Tulliez, M., Moreau Gachelin, F., Vainchenker, W. Villeval, J.L. (2006) JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood, 108, 1652 1660. (Pubitemid 44316134)
20. Levine, R., Wadleigh, M., Cools, J., Ebert, B., Wernig, G., Huntley, B., Boggon, T., Wlodarska, I., Clark, J., Moore, S., Adelsperger, J., Koo, S., Lee, J., Gabriel, G., Mercher, T., D'Andrea, A., Fröhling, S., Döhner, K., Marynen, P., Vandenberghe, P., Mesa, R., Tefferi, A., Griffin, J., Eck, M., Sellers, W., Meyerson, M., Golub, T., Lee, S. Gilliland, D. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387 397. (Pubitemid 40544655)
21. McCormack, M.P., Hall, M.A., Schoenwaelder, S.M., Zhao, Q., Ellis, S., Prentice, J.A., Clarke, A.J., Slater, N.J., Salmon, J.M., Jackson, S.P., Jane, S.M. Curtis, D.J. (2006) A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis. Blood, 108, 2248 2256. (Pubitemid 44497507)
22. Migliaccio, G., Di Pietro, R., di Giacomo, V., Di Baldassarre, A., Migliaccio, A.R., Maccioni, L., Galanello, R. Papayannopoulou, T. (2002) In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells, Molecules, and Diseases, 28, 169 180. (Pubitemid 34743751)
23. Moroni, E., Mastrangelo, T., Razzini, R., Cairns, L., Moi, P., Ottolenghi, S. Giglioni, B. (2000) Regulation of mouse p45 NF-E2 transcription by an erythroid-specific GATA-dependent intronic alternative promoter. Journal of Biological Chemistry, 275, 10567 10576. (Pubitemid 30202122)
24. Nussenzveig, R.H., Swierczek, S.I., Jelinek, J., Gaikwad, A., Liu, E., Verstovsek, S., Prchal, J.F. Prchal, J.T. (2007) Polycythemia vera is not initiated by JAK2V617F mutation. Experimental Hematology, 35, 32 38.
25. Prchal, J.F. Axelrad, A.A. (1974) Bone-marrow responses in polycythemia vera. New England Journal of Medicine, 290, 1382.
26. Rinaldi, C.R., Martinelli, V., Rinaldi, P., Ciancia, R. del Vecchio, L. (2008) GATA1 is overexpressed in patients with essential thrombocythemia and polycythemia vera but not in patients with primary myelofibrosis or chronic myelogenous leukemia. Leukaemia and Lymphoma, 49, 1416 1419. (Pubitemid 352015809)
27. Sayer, M.S., Tilbrook, P.A., Spadaccini, A., Ingley, E., Sarna, M.K., Williams, J.H., Andrews, N.C. Klinken, S.P. (2000) Ectopic expression of transcription factor NF-E2 alters the phenotype of erythroid and monoblastoid cells. Journal of Biological Chemistry, 275, 25292 25298. (Pubitemid 30687025)
28. Schiedlmeier, B., Klump, H., Will, E., Arman-Kalcek, G., Li, Z., Wang, Z., Rimek, A., Friel, J., Baum, C. Ostertag, W. (2003) High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation. Blood, 101, 1759 1768. (Pubitemid 36237571)
29. Scott, L.M., Tong, W., Levine, R.L., Scott, M.A., Beer, P.A., Stratton, M.R., Futreal, P.A., Erber, W.N., McMullin, M.F., Harrison, C.N., Warren, A.J., Gilliland, D.G., Lodish, H.F. Green, A.R. (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. New England Journal of Medicine, 356, 459 468. (Pubitemid 46193073)
30. Steimle, C., Lehmann, U., Temerinac, S., Goerttler, P.S., Kreipe, H., Meinhardt, G., Heimpel, H. Pahl, H.L. (2007) Biomarker analysis in polycythemia vera under interferon-alpha treatment: clonality, EEC, PRV-1, and JAK2 V617F. Annals of Hematology, 86, 239 244. (Pubitemid 46351398)
31. Theocharides, A., Boissinot, M., Girodon, F., Garand, R., Teo, S.S., Lippert, E., Talmant, P., Tichelli, A., Hermouet, S. Skoda, R.C. (2007) Leukemic blasts in transformed JAK2-V617F positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood, 110, 375 379. (Pubitemid 47026857)
32. Toki, T., Itoh, J., Arai, K., Kitazawa, J., Yokoyama, M., Igarashi, K., Yamamoto, M. Ito, E. (1996) Abundant expression of erythroid transcription factor P45 NF-E2 mRNA in human peripheral granurocytes. Biochemical Biophysical Research Communications, 219, 760 765.
33. Ugo, V., Marzac, C., Teyssandier, I., Larbret, F., Lecluse, Y., Debili, N., Vainchenker, W. Casadevall, N. (2004) Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera. Experimental Hematology, 32, 179 187. (Pubitemid 38177643)
34. Vannucchi, A.M., Pancrazzi, A., Bogani, C., Antonioli, E. Guglielmelli, P. (2006) A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis. Leukemia, 20, 1055 1060. (Pubitemid 43797297)
35. Weber, K., Bartsch, U., Stocking, C. Fehse, B. (2008) A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Molecular Therapy, 16, 698 706.
36. Wernig, G., Mercher, T., Okabe, R., Levine, R.L., Lee, B.H. Gilliland, D.G. (2006) Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood, 107, 4274 4281. (Pubitemid 43801351)
37. Westwood, N.B. Pearson, T.C. (1996) Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leukaemia and Lymphoma, 22, 95 103. (Pubitemid 26388538)
38. WHO (2001) Tumours of the Hemopoietic and Lymphoid Tissues. IARC Press, Lyon.
39. Xu, M., Bruno, E., Chao, J., Ni, H., Lindgren, V., Nunez, R., Mahmud, N., Finazzi, G., Fruchtman, S.M., Popat, U., Liu, E., Prchal, J.T., Rondelli, D., Barosi, G. Hoffman, R. (2005) The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis. Blood, 105, 1699 1705. (Pubitemid 40223693)
40. Zaleskas, V.M., Krause, D.S., Lazarides, K., Patel, N., Hu, Y., Li, S. Van Etten, R.A. (2006) Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. PLoS ONE, 1, e18.
41. Zhao, W., Kitidis, C., Fleming, M.D., Lodish, H.F. Ghaffari, S. (2006) Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood, 107, 907 915. (Pubitemid 43158401)